Oakworth Capital’s Boston Scientific BSX Stock Holding History

Oakworth Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$175K	Hold	4,072	–	–	0.01%	282
2026 Q1	$256K	Hold	4,072	–	–	0.01%	217
2025 Q4	$388K	Hold	4,072	–	–	0.02%	159
2025 Q3	$398K	Buy	4,072 +132	+3%	+$13.7K	0.02%	156
2025 Q2	$423K	Sell	3,940 -536	-12%	-$54.2K	0.03%	136
2025 Q1	$452K	Buy	4,476 +19	+0.4%	+$1.91K	0.03%	128
2024 Q4	$398K	Hold	4,457	–	–	0.03%	140
2024 Q3	$373K	Buy	4,457 +70	+2%	+$5.52K	0.03%	147
2024 Q2	$338K	Buy	4,387 +1,303	+42%	+$95.4K	0.02%	148
2024 Q1	$211K	Hold	3,084	–	–	0.02%	192
2023 Q4	$178K	Hold	3,084	–	–	0.01%	199
2023 Q3	$163K	Buy	3,084 +143	+5%	+$7.5K	0.01%	188
2023 Q2	$159K	Buy	2,941 +107	+4%	+$5.59K	0.01%	195
2023 Q1	$142K	Buy	2,834 +100	+4%	+$4.71K	0.01%	201
2022 Q4	$127K	Sell	2,734 -650	-19%	-$28.1K	0.01%	203
2022 Q3	$131K	Hold	3,384	–	–	0.01%	199
2022 Q2	$126K	Hold	3,384	–	–	0.01%	204
2022 Q1	$150K	Hold	3,384	–	–	0.01%	195
2021 Q4	$143K	Sell	3,384 -170	-5%	-$7.14K	0.01%	217
2021 Q3	$154K	Buy	3,554 +650	+22%	+$28.8K	0.01%	201
2021 Q2	$124K	Hold	2,904	–	–	0.01%	224
2021 Q1	$112K	Hold	2,904	–	–	0.01%	223
2020 Q4	$105K	Hold	2,904	–	–	0.01%	218
2020 Q3	$111K	Hold	2,904	–	–	0.02%	197
2020 Q2	$102K	Hold	2,904	–	–	0.02%	195
2020 Q1	$94K	Hold	2,904	–	–	0.02%	186
2019 Q4	$132K	Hold	2,904	–	–	0.02%	191
2019 Q3	$118K	Hold	2,904	–	–	0.02%	198
2019 Q2	$124K	Hold	2,904	–	–	0.02%	212
2019 Q1	$111K	Hold	2,904	–	–	0.02%	222
2018 Q4	$102K	Buy	2,904 +2,734	+1,608%	+$99.2K	0.02%	217
2018 Q3	$7K	Hold	170	–	–	﹤0.01%	485
2018 Q2	$6K	Hold	170	–	–	﹤0.01%	515
2018 Q1	$5K	Hold	170	–	–	﹤0.01%	505
2017 Q4	$4K	Hold	170	–	–	﹤0.01%	527
2017 Q3	$5K	Hold	170	–	–	﹤0.01%	530
2017 Q2	$5K	Hold	170	–	–	﹤0.01%	521
2017 Q1	$4K	Hold	170	–	–	﹤0.01%	531
2016 Q4	$3K	Hold	170	–	–	﹤0.01%	555
2016 Q3	$4K	Hold	170	–	–	﹤0.01%	516
2016 Q2	$4K	Hold	170	–	–	﹤0.01%	494
2016 Q1	$3K	Hold	170	–	–	﹤0.01%	467
2015 Q4	$3K	Hold	170	–	–	﹤0.01%	445
2015 Q3	$3K	Hold	170	–	–	﹤0.01%	366
2015 Q2	$3K	Hold	170	–	–	﹤0.01%	376
2015 Q1	$3K	Hold	170	–	–	﹤0.01%	385
2014 Q4	$2K	Hold	170	–	–	﹤0.01%	403
2014 Q3	$2K	Hold	170	–	–	﹤0.01%	376
2014 Q2	$2K	Sell	170 -170	-50%	-$2.21K	﹤0.01%	380
2014 Q1	$5K	Hold	340	–	–	﹤0.01%	327
2013 Q4	$4K	Buy	+340	New	+$4.02K	﹤0.01%	326

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

BPCE

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Oakworth Capital's BSX Position: Q2 2026 in Review

Oakworth Capital held its Boston Scientific (BSX) position steady in Q2 2026 at 4,072 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #282.

Oakworth Capital first reported a position in BSX in Q4 2013 and has held it in 51 quarters since. The position peaked at $452K in Q1 2025. 338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Oakworth Capital held 4,072 shares of Boston Scientific worth $175K as of Q2 2026.
Oakworth Capital left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up 0.01% of Oakworth Capital's portfolio in Q2 2026, its #282 holding.
Oakworth Capital first reported a position in Boston Scientific in Q4 2013 and has held it in 51 quarters since.
Oakworth Capital's Boston Scientific position peaked at $452K in Q1 2025.
338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.